CEA StAR opportunities
CEA StAR will have 12 PhD scholarship opportunities available at any of our partner sites.
Current PhD opportunities:
Please check back regularly as further PhD opportunities will be added.
Antimicrobial Mechanism of Action of Magnesium Oxide Products
Explore the mechanism of action of novel antibacterials using a range of genomic, phenotypic and physiological approaches, including genetic technologies (including WGS and TraDIS), high resolution microscopy, single cell microfluidics and flow cytometry.
Primary Supervisor: Dr Alysha Elliott, Institute for Molecular Bioscience
Development of Antibacterial Topical Formulations for Post-Production Wine By-Products
Develop a range of effective topical formulations to better treat and eradicate bacterial infections. The project will exploit the antimicrobial properties of post-wine production polyphenolic extracts and complexes with silver and other metallic nanoparticles.
Primary Supervisor: Dr Harendra Parekh, School of Pharmacy
Supervisor: Dr Zyta Ziora, Institute for Molecular Bioscience
Please check the UQ Graduate School Scholarship finder for the full advertisement coming soon!
What’s on offer:
- An ARC Stipend Scholarship for up to 3.5 years with possibility for 6-month extension (2023 stipend rate at $36,161)
- Dedicated funding to support research project and access to expertise and world-class research facilities.
- Real-world industry experience through a one-year (equivalent) placement with industry
- Access to specialised training and development opportunities, including Centre Bootcamps and conferences, with support and mentorship from academic and industry experts.
- Funding opportunities for national and international conferences, meetings, and symposia.
- Opportunity to manage and lead an industry-driven complex research project with real-world applications.
For enquiries about the Centre, please contact the Centre Manager at cea-star@uq.edu.au
CEA StAR is funded by the Australian Research Council Industrial Transformation Research Program (IC220100050) and its project Partners which include:
- The University of Adelaide
- Calix Ltd
- Neoculi Pty Ltd
- Edenvale Beverages
- Cluster Biotechnology Pty Ltd
- Invion Limited
- MGI Australia Pty Ltd